Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
This grant funds a unit to manage, coordinate, and support data, logistics, and collaboration for early pancreatic cancer detection research within the Pancreatic Cancer Detection Consortium.
Browse similar grants
Funder: National Institutes of Health
Due Dates: May 25, 2027 (application deadline)
Funding Amounts: $500,000 award ceiling; $825,000 estimated total program funding
Summary: Supports a management and data coordination unit for research on early detection of pancreatic ductal adenocarcinoma.
Key Information: Clinical trials are not allowed; foreign organizations and foreign components are ineligible.
Description
The National Cancer Institute (NCI) seeks to establish the Management and Data Coordination Unit (MDCU), one of two scientific components of the Pancreatic Cancer Detection Consortium. The consortium studies early detection of pancreatic ductal adenocarcinoma and characterizes precursor lesions to identify patients at high risk of progression to cancer. This work continues a research priority identified in NCI’s 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma.
The MDCU will support collaborative study design, protocol development, statistical analysis, coordination, and data management. It will also help build a biorepository and provide organizational and logistical support for consortium activities. The award is a cooperative agreement, and clinical trials are not allowed.
